Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology/Urology
Disease Category: Gout (Hyperuricemia)

Trial Information

SURGE: Study Utilizing Rilonacept in Gout Exacerbations. A medical research study evaluating an investigational medicine for gout flares, and the pain associated with them.

This study is evaluating an investigational medication for the relief of pain associated with acute gout flares. The medication is rilonacept, and it is a recombinant fusion protein. Although rilonacept is not currently approved for the treatment of gout, it is approved for the treatment of other conditions. Qualified patients will be randomly assigned to receive either rilonacept alone, rilonacept in combination with indomethacin (a drug approved for the treatment of gout attacks), or indomethacin alone. Participation in the SURGE study could last a total of 5 weeks, with up to 5 visits to the study clinic. Qualified participants will receive study medicine as well as study-related medical evaluations at no cost. Reimbursement for time and travel may also be available.

Inclusion Criteria

• 18-70 years of age, AND
• Currently experiencing a gout flare, OR
• Have previously experienced a gout flare, and are willing to participate the next time you have a gout flare

Exclusion Criteria

• You participated in a previous rilonacept study
• You are currently taking a blood thinner such as warfarin, Coumadin, Plavix, or clopidogrel
• You had cancer within the past 5 years, exception is non-melanoma skin cancer

Sonya Robinson, CCRC, Study Coordinator
Alpha Medical Research
2984 Alafaya Trail, Suite 2020
Oviedo, FL 32765
Phone: 407-588-1640
Fax: 407-588-1645
EMail: srobinson@pattersonmd.net

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.